Treatment Plan for Mild OSA with Periodic Limb Movements in Sleep
For this patient with mild OSA (AHI 5-14 using 3% desaturation criteria) and periodic limb movements in sleep, initiate treatment with gabapentin enacarbil, gabapentin, or pregabalin as first-line therapy for the PLMS/RLS component, while simultaneously checking iron parameters (ferritin and transferrin saturation) and considering CPAP therapy for the mild OSA.
Addressing the Periodic Limb Movements First
The 2025 AASM guidelines provide clear direction for PLMS treatment 1:
Strong recommendations (use these first):
- Gabapentin enacarbil (strongest evidence, moderate certainty)
- Gabapentin (strong recommendation, moderate certainty)
- Pregabalin (strong recommendation, moderate certainty)
These alpha-2-delta ligands are now the preferred first-line agents, replacing dopamine agonists which are now recommended against for standard use due to augmentation risk 1.
Iron Assessment is Critical
Check iron parameters immediately:
- Ferritin level
- Transferrin saturation
If ferritin is low or transferrin saturation is reduced, IV ferric carboxymaltose is strongly recommended 1. Even oral ferrous sulfate has conditional support if iron parameters are suboptimal 1.
Avoid Dopamine Agonists
The guidelines explicitly suggest against standard use of 1:
- Pramipexole
- Ropinirole
- Rotigotine
- Levodopa
These may only be considered short-term in patients who prioritize immediate symptom relief over long-term augmentation risk, but this is not the recommended approach.
Managing the Mild OSA Component
CPAP Consideration
For mild OSA (AHI 5-14), CPAP remains the gold standard when tolerated 2. However, the interaction between OSA and PLMS is complex:
Key evidence on CPAP and PLMS:
- CPAP may improve RLS symptoms in over 70% of patients with comorbid OSA-RLS 3
- However, CPAP can also "unmask" underlying PLMD in some patients, particularly those with more severe OSA 4
- In mild OSA specifically, CPAP may actually reduce PLMS by eliminating respiratory effort-related arousals that trigger leg movements 4
- Recent data shows 36% of patients experience PLMS resolution with CPAP, while 16% worsen and 48% persist 5
For this patient with mild OSA: CPAP is more likely to help than harm the PLMS, as mild OSA patients tend to have PLMS triggered by subclinical respiratory events rather than true underlying PLMD 4.
Alternative to CPAP
If CPAP is not tolerated or declined, a mandibular advancement device (MAD) can be considered for mild OSA, though it has less impact on AHI reduction than CPAP 2. The guidelines suggest CPAP over MAD, but in mild-moderate OSA where sleepiness and quality of life are similar between treatments, MAD is a reasonable alternative.
Algorithmic Treatment Approach
Step 1: Check ferritin and transferrin saturation
Step 2: Initiate alpha-2-delta ligand therapy
Step 3: Trial CPAP for mild OSA
- Given mild severity, CPAP may resolve PLMS by eliminating respiratory triggers 4
- Monitor for PLMS response at follow-up titration study
Step 4: Reassess at 4-6 weeks
- If PLMS persist despite CPAP and medication, this suggests true underlying PLMD rather than OSA-triggered movements 6, 7
- If PLMS worsen with CPAP (CPAP-emergent PLMS), this is more common in severe OSA but can occur; consider optimizing CPAP settings or adjusting medication dose 5, 7
Important Caveats
The "abrupt arousal from delta sleep with increased heart rate" noted in the diagnostic impressions warrants attention. This could represent:
- A confusional arousal
- A PLMS-associated arousal
- An OSA-related arousal
This finding supports treating both conditions simultaneously rather than sequentially.
Avoid these common pitfalls:
- Do not start dopamine agonists as first-line (outdated approach with high augmentation risk) 1
- Do not assume CPAP alone will resolve PLMS—it may help, worsen, or have no effect depending on PLMS etiology 6, 8
- Do not overlook iron deficiency—it's a treatable cause with strong evidence 1
Male sex, higher BMI, and hypoxemia predict persistent PLMS despite CPAP 5, so if this patient fits this profile, be prepared to optimize pharmacologic therapy even with good CPAP adherence.